Patients with symptomatic carotid artery disease should be managed by a multidisciplinary team including neurologists, vascular surgeons and interventionalists. Duplex ultrasound is the most widely used diagnostic modality to assess carotid disease, followed by additional imaging tests (CT- or MR-angiography) to confirm the severity of the stenosis, detect brain lesions, and assess intracranial circulation as well as the supra-aortic anatomy. Although overall randomized trial results favored (CEA) over carotid artery stenting (CAS) in symptomatic patients, this was likely related to the insufficient expertise of the endovascular specialists in several of the trials. CAS should be considered as a valid alternative to CEA in patients with favorable anatomy and in those at high-surgical risk, provided it is performed by experienced operators in high volume centers. Under those circumstances, it is reasonable to offer the patients the two options (CEA or CAS) after description of pros and cons of each therapy. CAS results may be further improved by better patient selection, new techniques, and technology advancements.

Symptomatic Carotid Artery Disease : Revascularization / P. Montorsi, S. Galli, P.M. Ravagnani, M. Roffi. - In: PROGRESS IN CARDIOVASCULAR DISEASES. - ISSN 0033-0620. - 59:6(2017), pp. 601-611. [10.1016/j.pcad.2017.04.002]

Symptomatic Carotid Artery Disease : Revascularization

P. Montorsi;
2017

Abstract

Patients with symptomatic carotid artery disease should be managed by a multidisciplinary team including neurologists, vascular surgeons and interventionalists. Duplex ultrasound is the most widely used diagnostic modality to assess carotid disease, followed by additional imaging tests (CT- or MR-angiography) to confirm the severity of the stenosis, detect brain lesions, and assess intracranial circulation as well as the supra-aortic anatomy. Although overall randomized trial results favored (CEA) over carotid artery stenting (CAS) in symptomatic patients, this was likely related to the insufficient expertise of the endovascular specialists in several of the trials. CAS should be considered as a valid alternative to CEA in patients with favorable anatomy and in those at high-surgical risk, provided it is performed by experienced operators in high volume centers. Under those circumstances, it is reasonable to offer the patients the two options (CEA or CAS) after description of pros and cons of each therapy. CAS results may be further improved by better patient selection, new techniques, and technology advancements.
Carotid artery stenosis; Carotid endarterectomy; Carotid stenting; Embolic protection; Randomized trials; Review; Stents; Carotid Stenosis; Evidence-Based Medicine; Humans; Patient Selection; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stents; Stroke; Time Factors; Treatment Outcome; Angioplasty; Endarterectomy, Carotid; Cardiology and Cardiovascular Medicine
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0033062017300531-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 783.72 kB
Formato Adobe PDF
783.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/628232
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact